203 related articles for article (PubMed ID: 22049059)
1. Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.
Hsieh TH; Tsai CF; Hsu CY; Kuo PL; Lee JN; Chai CY; Wang SC; Tsai EM
FASEB J; 2012 Feb; 26(2):778-87. PubMed ID: 22049059
[TBL] [Abstract][Full Text] [Related]
2. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells.
Hsieh TH; Tsai CF; Hsu CY; Kuo PL; Lee JN; Chai CY; Hou MF; Chang CC; Long CY; Ko YC; Tsai EM
Toxicol Sci; 2012 Aug; 128(2):365-76. PubMed ID: 22552774
[TBL] [Abstract][Full Text] [Related]
3. Biological impact of phthalates.
Mankidy R; Wiseman S; Ma H; Giesy JP
Toxicol Lett; 2013 Feb; 217(1):50-8. PubMed ID: 23220035
[TBL] [Abstract][Full Text] [Related]
4. Lower concentrations of phthalates induce proliferation in human breast cancer cells.
Chen FP; Chien MH
Climacteric; 2014 Aug; 17(4):377-84. PubMed ID: 24228746
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of estrogen receptor alpha gene by phthalates.
Kang SC; Lee BM
J Toxicol Environ Health A; 2005 Dec; 68(23-24):1995-2003. PubMed ID: 16326419
[TBL] [Abstract][Full Text] [Related]
6. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells.
Kim IY; Han SY; Moon A
J Toxicol Environ Health A; 2004 Dec; 67(23-24):2025-35. PubMed ID: 15513900
[TBL] [Abstract][Full Text] [Related]
7. Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling.
Tsai CF; Hsieh TH; Lee JN; Hsu CY; Wang YC; Lai FJ; Kuo KK; Wu HL; Tsai EM; Kuo PL
BMC Cancer; 2014 Aug; 14():556. PubMed ID: 25081364
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).
Picard K; Lhuguenot JC; Lavier-Canivenc MC; Chagnon MC
Toxicol Appl Pharmacol; 2001 Apr; 172(2):108-18. PubMed ID: 11298497
[TBL] [Abstract][Full Text] [Related]
9. miR-19 targeting of PTEN mediates butyl benzyl phthalate-induced proliferation in both ER(+) and ER(-) breast cancer cells.
Wu J; Jiang Y; Cao W; Li X; Xie C; Geng S; Zhu M; Liang Z; Zhu J; Zhu W; Wu R; Ma X; Huang C; Yang X; Wang S; Zhong C
Toxicol Lett; 2018 Oct; 295():124-133. PubMed ID: 29864457
[TBL] [Abstract][Full Text] [Related]
10. Benzyl butyl phthalate induces necrosis by AhR mediation of CYP1B1 expression in human granulosa cells.
Chen HS; Chiang PH; Wang YC; Kao MC; Shieh TH; Tsai CF; Tsai EM
Reprod Toxicol; 2012 Jan; 33(1):67-75. PubMed ID: 22138065
[TBL] [Abstract][Full Text] [Related]
11. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
Lee HR; Hwang KA; Choi KC
Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
[TBL] [Abstract][Full Text] [Related]
12. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
14. Effects of phthalates on the human corneal endothelial cell line B4G12.
Krüger T; Cao Y; Kjærgaard SK; Knudsen LE; Bonefeld-Jørgensen EC
Int J Toxicol; 2012; 31(4):364-71. PubMed ID: 22723514
[TBL] [Abstract][Full Text] [Related]
15. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions.
Ghisari M; Bonefeld-Jorgensen EC
Toxicol Lett; 2009 Aug; 189(1):67-77. PubMed ID: 19463926
[TBL] [Abstract][Full Text] [Related]
16. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
17. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
18. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
20. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
Buteau-Lozano H; Velasco G; Cristofari M; Balaguer P; Perrot-Applanat M
J Endocrinol; 2008 Feb; 196(2):399-412. PubMed ID: 18252963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
